Hope for brain injury patients: stem cells tested in expanded access trial
NCT ID NCT07164482
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This expanded access study offers stem cell therapy (HB-adMSCs) to up to 8 people with traumatic or non-traumatic brain injury who were not eligible for a related trial. Participants receive 6 intravenous infusions over 16 weeks. The goal is to evaluate safety and whether the treatment can improve outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells)
What this could lead to
If this works, it could point toward a treatment that helps repair brain damage and improve function after injury.
What could go wrong
This is a very small expanded access study (up to 8 patients) with no control group, so results may not be generalizable. Stem cell treatments carry risks like infusion reactions or unknown long-term effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hope Biosciences Research Foundation
AVAILABLEHouston, Texas, 77478, United States